Dr. RR Baliga’s Philosophical Snippets: Kapila (India, c. 600 BCE) – Founder of Samkhya Philosophy
Dr. Baliga's 'Got Knowledge Doc?' PODKASTS
Kapila: Founder of Samkhya Philosophy Kapila (7th–6th century BCE) is regarded as the founder of the Samkhya school, one of the six orthodox systems of Hindu philosophy. Known for his rational and dualistic approach, he emphasized the distinction between Purusha (consciousness) and Prakriti (matter). His teachings are captured in the Samkhya Sutras and the Bhagavata Purana, where he elaborated on metaphysics, self-realization, and liberation from suffering. Kapila’s influence extends to Hinduism, Buddhism, and Jainism, making him a pivotal figure in ancient Indian philosophy.
info_outline
10-year outcomes from the SCOT- HEART Study--Lancet
Dr. Baliga's 'Got Knowledge Doc?' PODKASTS
Coronary CT angiography-guided management of patients with stable chest pain: 10-year outcomes from the SCOT- HEART randomised controlled trial in Scotland Michelle C Williams, Ryan Wereski, Christopher Tuck, Philip D Adamson, Anoop S V Shah, Edwin J R van Beek, Giles Roditi, Colin Berry,Nicholas Boon, Marcus Flather, Steff Lewis, John Norrie, Adam D Timmis, Nicholas L Mills, Marc R Dweck, David E Newby, on behalf of theSCOT-HEART Investigators* Summary Background The Scottish Computed Tomography of the Heart (SCOT-HEART) trial demonstrated that management guided by coronary CT angiography...
info_outline
Dr. RR Baliga’s Philosophical Discourses: Anaximander (Greece, c. 610–546 BCE) – Pre-Socratic Philosopher
Dr. Baliga's 'Got Knowledge Doc?' PODKASTS
Anaximander of Miletus (c. 610 – c. 546 BCE), a pre-Socratic philosopher and student of Thales, was a pioneer of cosmology, astronomy, and natural philosophy. He introduced the concept of the apeiron (infinite) as the origin of all things, developed early theories on evolution, and created one of the first world maps. His revolutionary ideas laid the groundwork for scientific thinking and inspired generations of philosophers and scientists.
info_outline
Debunking Myths About Protein Deficiency in Indian Vegetarians
Dr. Baliga's 'Got Knowledge Doc?' PODKASTS
“The Protein Puzzle: Debunking Myths About Protein Deficiency in India” This episode explores and debunks the myth of protein deficiency in India, highlighting that most Indians meet their protein needs through balanced diets. It explains the Protein-to-Energy Ratio (PER) and how traditional food pairings like cereals and legumes enhance protein quality. Key insights include varying protein needs across age groups, the risks of overconsumption, and practical tips for improving dietary protein through affordable, accessible options. The episode emphasizes that...
info_outline
Dr. RR Baliga’s Philosophical Discourses: Gargi Vachaknavi (India, c. 700 BCE) – Vedic Philosopher
Dr. Baliga's 'Got Knowledge Doc?' PODKASTS
Gargi Vachaknavi, an esteemed philosopher and Vedic scholar of ancient India, is celebrated as one of the earliest female intellectuals in recorded history. Known for her profound knowledge of Brahma Vidya, she engaged in rigorous philosophical debates, including a renowned discourse with sage Yajnavalkya on the nature of existence and the ultimate reality. Revered as a Brahmavadini, Gargi contributed significantly to the intellectual and spiritual traditions of Vedic India, inspiring generations with her wisdom and critical thinking.
info_outline
Dr. RR Baliga’s Philosophical Discourses: Thales of Miletus (Greece, c. 624–546 BCE) – Pre-Socratic Philosopher
Dr. Baliga's 'Got Knowledge Doc?' PODKASTS
“Discover the legacy of Thales of Miletus, the first Greek philosopher and one of the Seven Sages. Known for proposing ‘all is water,’ pioneering geometry, and predicting a solar eclipse, he laid the foundation for science and rational inquiry. #Philosophy #Thales”
info_outline
Dr RR Baliga's Philosophical Discourses: Yajnavalkya (India, c. 800 BCE) – Vedic Philosopher
Dr. Baliga's 'Got Knowledge Doc?' PODKASTS
Explore timeless wisdom with Dr. RR Baliga’s Philosophical Discourses! Dive into the teachings of Yajnavalkya: Vedic Sage and Philosopher and more, blending ancient philosophy with modern insights.
info_outline
COVID-19 in Patients with Heart Disease and Cancer
Dr. Baliga's 'Got Knowledge Doc?' PODKASTS
COVID-19 in Patients with Heart Disease and Cancer
info_outline
EKG| Heart Block? | Dr RR Baliga's 'MUST KNOW EKG' Podkast for Physicians
Dr. Baliga's 'Got Knowledge Doc?' PODKASTS
Not Medical Advice or Opinion
info_outline
Valvular Heart Disease ACC/AHA 2021 Guideline Update
Dr. Baliga's 'Got Knowledge Doc?' PODKASTS
info_outlineCoronary CT angiography-guided management of patients
with stable chest pain: 10-year outcomes from the SCOT-
HEART randomised controlled trial in Scotland
Michelle C Williams, Ryan Wereski, Christopher Tuck, Philip D Adamson, Anoop S V Shah, Edwin J R van Beek, Giles Roditi, Colin Berry,Nicholas Boon, Marcus Flather, Steff Lewis, John Norrie, Adam D Timmis, Nicholas L Mills, Marc R Dweck, David E Newby, on behalf of theSCOT-HEART Investigators*
Summary
Background The Scottish Computed Tomography of the Heart (SCOT-HEART) trial demonstrated that management
guided by coronary CT angiography (CCTA) improved the diagnosis, management, and outcome of patients with
stable chest pain. We aimed to assess whether CCTA-guided care results in sustained long-term improvements in
management and outcomes.
Methods SCOT-HEART was an open-label, multicentre, parallel group trial for which patients were recruited from
12 outpatient cardiology chest pain clinics across Scotland. Eligible patients were aged 18–75 years with symptoms of
suspected stable angina due to coronary heart disease. Patients were randomly assigned (1:1) to standard of care plus
CCTA or standard of care alone. In this prespecified 10-year analysis, prescribing data, coronary procedural
interventions, and clinical outcomes were obtained through record linkage from national registries. The primary
outcome was coronary heart disease death or non-fatal myocardial infarction on an intention-to-treat basis. This trial
is registered at ClinicalTrials.gov (NCT01149590) and is complete.
Findings Between Nov 18, 2010, and Sept 24, 2014, 4146 patients were recruited (mean age 57 years [SD 10], 2325 [56·1%] male, 1821 [43·9%] female), with 2073 randomly assigned to standard care and CCTA and 2073 to standard care
alone. After a median of 10·0 years (IQR 9·3–11·0), coronary heart disease death or non-fatal myocardial infarction
was less frequent in the CCTA group compared with the standard care group (137 [6·6%] vs 171 [8·2%]; hazard ratio
[HR] 0·79 [95% CI 0·63–0·99], p=0·044). Rates of all-cause, cardiovascular, and coronary heart disease death, and
non-fatal stroke, were similar between the groups (p>0·05 for all), but non-fatal myocardial infarctions (90 [4·3%] vs
124 [6·0%]; HR 0·72 [0·55–0·94], p=0·017) and major adverse cardiovascular events (172 [8·3%] vs 214 [10·3%];
HR 0·80 [0·65–0·97], p=0·026) were less frequent in the CCTA group. Rates of coronary revascularisation procedures
were similar (315 [15·2%] vs 318 [15·3%]; HR 1·00 [0·86–1·17], p=0·99) but preventive therapy prescribing remained
more frequent in the CCTA group (831 [55·9%] of 1486 vs 728 [49·0%] of 1485 patients with available data; odds ratio
1·17 [95% CI 1·01–1·36], p=0·034).
Interpretation After 10 years, CCTA-guided management of patients with stable chest pain was associated with a
sustained reduction in coronary heart disease death or non-fatal myocardial infarction. Identification of coronary
atherosclerosis by CCTA improves long-term cardiovascular disease prevention in patients with stable chest pain.